Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Multicenter Evaluation of the Use of Topically Administered Danazol Versus Placebo in Subjects With Pain Associated With Fibrocystic Breast Disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jul 2009
Price :
$35
*
At a glance
- Drugs Danazol (Primary)
- Indications Fibrocystic breast disorders
- Focus Therapeutic Use
- Sponsors FemmePharma Global Healthcare
- 10 Jul 2009 New trial record